Juvenile idiopathic arthritis

The Lancet

Volumn 377, Issue 9783, 2011, Pages 2138-2149

  Prakken, Berent ^a   Albani, Salvatore ^b   Martini, Alberto ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; ALKYLATING AGENT; ANTINUCLEAR ANTIBODY; CALGRANULIN A; CANAKINUMAB; CORTICOSTEROID; CYCLOSPORIN A; ETANERCEPT; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 6; LEFLUNOMIDE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYDRIATIC AGENT; PROTEIN S 100; PROTEIN S 100A9; RHEUMATOID FACTOR; TOCILIZUMAB; TRANSCRIPTION FACTOR FOXP3; TRIAMCINOLONE HEXACETONIDE; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BONE RADIOGRAPHY; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG INDUCED CANCER; DRUG SAFETY; ENTHESITIS; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL THERAPY; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; SYNOVITIS; SYSTEMIC DISEASE; TH17 CELL; UVEITIS;

EID: 79959370461     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60244-4     Document Type: Review

References (137)

1. A Ravelli, A Martini Juvenile idiopathic arthritis Lancet 369 2007 767 778
2. A Martini, DJ Lovell Juvenile idiopathic arthritis: state of the art and future perspectives Ann Rheum Dis 69 2010 1260 1263
3. RE Petty, TR Southwood, P Manners et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 J Rheumatol 31 2004 390 392 (Pubitemid 38160763)
4. BJ Prakken, S Albani Using biology of disease to understand and guide therapy of JIA Best Pract Res Clin Rheumatol 23 2009 599 608
5. K Nistala, LR Wedderburn Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis Rheumatology (Oxford) 48 2009 602 606
6. M Frosch, J Roth New insights in systemic juvenile idiopathic arthritis - from pathophysiology to treatment Rheumatology (Oxford) 47 2008 121 125 (Pubitemid 351168217)
7. S Thompson, M Barnes, T Griffin, A Grom, DN Glass Heterogeneity in JIA, impact of molecular profiling based on DNA polymorphism and gene expression patterns Arthritis Rheum 62 2010 2611 2615
8. SL Masters, A Simon, I Aksentijevich, DL Kastner Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*) Annu Rev Immunol 27 2009 621 668
9. F De Benedetti, A Martini Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease? J Rheumatol 25 1998 203 207
10. S Yokota, T Imagawa, M Mori et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial Lancet 371 2008 998 1006 (Pubitemid 351389534)
11. F De Benedetti, H Brunner, N Ruperto et al. Efficacy and safety of tocilizumab in patients with systemic juvenile idiopathic arthritis (sJIA): 12-week data from the phase 3 tender trial Ann Rheum Dis 69 suppl 146 2010 146
12. V Pascual, F Allantaz, E Arce, M Punaro, J Banchereau Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade J Exp Med 201 2005 1479 1486 (Pubitemid 40664091)
13. M Gattorno, A Piccini, D Lasiglie et al. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis Arthritis Rheum 58 2008 1505 1515 (Pubitemid 351705940)
14. M van Rossum, R van Soesbergen, S de Kort et al. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis J Rheumatol 30 2003 825 828 (Pubitemid 36402779)
15. RA Colbert Classification of juvenile spondyloarthritis: enthesitis-related arthritis and beyond Nat Rev Rheumatol 6 2010 477 485
16. A Martini Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous disease entities in juvenile idiopathic arthritis? J Rheumatol 30 2003 1900 1903 (Pubitemid 37075533)
17. A Ravelli, E Felici, S Magni-Manzoni et al. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease Arthritis Rheum 52 2005 826 832 (Pubitemid 40365105)
18. A Ravelli, GC Varnier, S Oliveira et al. Antinuclear antibody positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis Arthritis Rheum 63 2011 8
19. TR Southwood, RE Petty, PN Malleson et al. Psoriatic arthritis in children Arthritis Rheum 32 1989 1007 1013 (Pubitemid 19218380)
20. ML Stoll, P Lio, RP Sundel, PA Nigrovic Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis Arthritis Rheum 59 2008 51 58 (Pubitemid 351171878)
21. ML Stoll, D Zurakowski, LE Nigrovic, DP Nichols, RP Sundel, PA Nigrovic Patients with juvenile psoriatic arthritis comprise two distinct populations Arthritis Rheum 54 2006 3564 3572 (Pubitemid 44737168)
22. TA Griffin, MG Barnes, NT Ilowite et al. Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets Arthritis Rheum 60 2009 2113 2123
23. MG Barnes, AA Grom, SD Thompson et al. Biological similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis Arthritis Rheum 62 2010 3249 3258
24. A Gregorio, C Gambini, V Gerloni et al. Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration Rheumatology (Oxford) 46 2007 308 313 (Pubitemid 46189794)
25. JA Hollenbach, SD Thompson, TL Bugawan et al. Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects Arthritis Rheum 62 2010 1781 1791
26. S Magni-Manzoni, O Epis, A Ravelli et al. Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis Arthritis Rheum 61 2009 1497 1504
27. ME Rooney, C McAllister, JF Burns Ankle disease in juvenile idiopathic arthritis: ultrasound findings in clinically swollen ankles J Rheumatol 36 2009 1725 1729
28. RK Saurenmann, AV Levin, BM Feldman, RM Laxer, R Schneider, ED Silverman Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis Arthritis Rheum 62 2010 1824 1828
29. RK Saurenmann, AV Levin, BM Feldman, RM Laxer, R Schneider, ED Silverman Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents J Pediatr 149 2006 833 836 (Pubitemid 44816346)
30. RK Saurenmann, AV Levin, BM Feldman et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study Arthritis Rheum 56 2007 647 657
31. P Woo, RA Colbert An overview of genetics of paediatric rheumatic diseases Best Pract Res Clin Rheumatol 23 2009 589 597
32. DN Glass, EH Giannini Juvenile rheumatoid arthritis as a complex genetic trait Arthritis Rheum 42 1999 2261 2268 (Pubitemid 30333403)
33. S Prahalad, MH Ryan, ES Shear, SD Thompson, DN Glass, EH Giannini Twins concordant for juvenile rheumatoid arthritis Arthritis Rheum 43 2000 2611 2612
34. S Prahalad, MH Ryan, ES Shear, SD Thompson, EH Giannini, DN Glass Juvenile rheumatoid arthritis: linkage to HLA demonstrated by allele sharing in affected sibpairs Arthritis Rheum 43 2000 2335 2338
35. S Prahalad, DN Glass A comprehensive review of the genetics of juvenile idiopathic arthritis Pediatr Rheumatol Online J 6 2008 11
36. S Prahalad Genetics of juvenile idiopathic arthritis: an update Curr Opin Rheumatol 16 2004 588 594 (Pubitemid 39128329)
37. P Rosen, S Thompson, D Glass Non-HLA gene polymorphisms in juvenile rheumatoid arthritis Clin Exp Rheumatol 21 2003 650 656 (Pubitemid 37236463)
38. SD Thompson, MB Moroldo, L Guyer et al. A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage Arthritis Rheum 50 2004 2920 2930 (Pubitemid 39209531)
39. MS Fife, A Gutierrez, EM Ogilvie et al. Novel IL10 gene family associations with systemic juvenile idiopathic arthritis Arthritis Res Ther 8 2006 R148
40. EM Ogilvie, A Khan, M Hubank, P Kellam, P Woo Specific gene expression profiles in systemic juvenile idiopathic arthritis Arthritis Rheum 56 2007 1954 1965 (Pubitemid 47110394)
41. MG Barnes, AA Grom, SD Thompson et al. Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis Arthritis Rheum 60 2009 2102 2112
42. PJ Hunter, K Nistala, N Jina et al. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression Arthritis Rheum 62 2010 896 907
43. N Fall, M Barnes, S Thornton et al. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome Arthritis Rheum 56 2007 3793 3804 (Pubitemid 350100712)
44. N Knowlton, K Jiang, MB Frank et al. The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states Arthritis Rheum 60 2009 892 900
45. B Andersson Gare Juvenile arthritis-who gets it, where and when? A review of current data on incidence and prevalence Clin Exp Rheumatol 17 1999 367 374 (Pubitemid 29265689)
46. E Zonneveld-Huijssoon, A Ronaghy, MA Van Rossum et al. Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis Arthritis Rheum 56 2007 639 646
47. MW Heijstek, GC Pileggi, E Zonneveld-Huijssoon et al. Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis Ann Rheum Dis 66 2007 1384 1387 (Pubitemid 47492487)
48. Ronaghy A, de Jager W, Zonneveld-Huijssoon E, et al. Vaccination leads to an aberrant FOXP3 T cell response in non-remitting Juvenile Idiopathic Arthritis. Ann Rheum Dis (in press).
49. LR Wedderburn, A Patel, H Varsani, P Woo Divergence in the degree of clonal expansions in inflammatory T cell subpopulations mirrors HLA-associated risk alleles in genetically and clinically distinct subtypes of childhood arthritis Int Immunol 13 2001 1541 1550 (Pubitemid 33133881)
50. LR Wedderburn, N Robinson, A Patel, H Varsani, P Woo Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis Arthritis Rheum 43 2000 765 774
51. JN Jarvis, K Jiang, MB Frank et al. Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis Arthritis Rheum 60 2009 1488 1495
52. JN Jarvis, MM Diebold, MK Chadwell, M Iobidze, HT Moore Composition and biological behaviour of immune complexes isolated from synovial fluid of patients with juvenile rheumatoid arthritis (JRA) Clin Exp Immunol 100 1995 514 518
53. D Foell, H Wittkowski, I Hammerschmidt et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations Arthritis Rheum 50 2004 1286 1295 (Pubitemid 38480840)
54. M Gattorno, P Facchetti, F Ghiotto et al. Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype Clin Exp Immunol 109 1997 4 11 (Pubitemid 27293876)
55. M Gattorno, A Gregorio, F Ferlito et al. Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis Rheumatology (Oxford) 43 2004 1091 1096 (Pubitemid 39232812)
56. M Gattorno, I Prigione, F Morandi et al. Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis Arthritis Res Ther 7 2005 R256 R267
57. DS Pharoah, H Varsani, RW Tatham et al. Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells Arthritis Res Ther 8 2006 R50
58. W de Jager, EP Hoppenreijs, NM Wulffraat, LR Wedderburn, W Kuis, BJ Prakken Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study Ann Rheum Dis 66 2007 589 598 (Pubitemid 46707126)
59. C Faber, H Morbach, SK Singh, HJ Girschick Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis Ann Rheum Dis 65 2006 1351 1356 (Pubitemid 44620446)
60. S Sakaguchi, N Sakaguchi, M Asano, M Itoh, M Toda Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) - breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151 1164
61. S Hori, T Takahashi, S Sakaguchi Control of autoimmunity by naturally arising regulatory CD4+ T cells Adv Immunol 81 2003 331 371 (Pubitemid 38009046)
62. CL Bennett, J Christie, F Ramsdell et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 Nat Genet 27 2001 20 21 (Pubitemid 32044513)
63. IM de Kleer, LR Wedderburn, LS Taams et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis J Immunol 172 2004 6435 6443 (Pubitemid 38621253)
64. I de Kleer, B Vastert, M Klein et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network Blood 107 2006 1696 1702 (Pubitemid 43242411)
65. IM de Kleer, SM Kamphuis, GT Rijkers et al. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10 Arthritis Rheum 48 2003 2001 2010 (Pubitemid 36828695)
66. CR Ruprecht, M Gattorno, F Ferlito et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia J Exp Med 201 2005 1793 1803 (Pubitemid 41002898)
67. Y Vercoulen, EJ Wehrens, NH van Teijlingen, W de Jager, JM Beekman, BJ Prakken Human regulatory T cell suppressive function is independent of apoptosis induction in activated effector T cells PLoS One 4 2009 e7183
68. EJ Wehrens, F van Wijk, ST Roord, S Albani, BJ Prakken Treating arthritis by immunomodulation: is there a role for regulatory T cells? Rheumatology (Oxford) 49 2010 1632 1644
69. H Moncrieffe, K Nistala, Y Kamhieh et al. High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population J Immunol 185 2010 134 143
70. I de Kleer, Y Vercoulen, M Klein et al. CD30 discriminates heat shock protein 60-induced FOXP3+ CD4+ T cells with a regulatory phenotype J Immunol 185 2010 2071 2079
71. Y Vercoulen, NH van Teijlingen, IM de Kleer, S Kamphuis, S Albani, BJ Prakken Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new? Arthritis Res Ther 11 2009 231
72. S Kamphuis, S Albani, BJ Prakken Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis Expert Opin Biol Ther 6 2006 579 589 (Pubitemid 43837185)
73. S Kamphuis, W Kuis, W de Jager et al. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis Lancet 366 2005 50 56 (Pubitemid 40956530)
74. W van Eden, R van der Zee, B Prakken Heat-shock proteins induce T-cell regulation of chronic inflammation Nat Rev Immunol 5 2005 318 330 (Pubitemid 40516157)
75. M Massa, M Passalia, SM Manzoni et al. Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis Arthritis Rheum 56 2007 1648 1657 (Pubitemid 46764094)
76. F Flores-Borja, EC Jury, C Mauri, MR Ehrenstein Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis Proc Natl Acad Sci USA 105 2008 19396 19401
77. S Nadkarni, C Mauri, MR Ehrenstein Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta J Exp Med 204 2007 33 39 (Pubitemid 46148753)
78. K Nistala, H Moncrieffe, KR Newton, H Varsani, P Hunter, LR Wedderburn Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers Arthritis Rheum 58 2008 875 887 (Pubitemid 351364887)
79. K Nistala, S Adams, H Cambrook et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment Proc Natl Acad Sci USA 107 2010 14751 14756
80. SJ Vastert, R van Wijk, LE D'Urbano et al. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis Rheumatology (Oxford) 49 2010 441 449
81. SJ Vastert, W Kuis, AA Grom Systemic JIA: new developments in the understanding of the pathophysiology and therapy Best Pract Res Clin Rheumatol 23 2009 655 664
82. HJ van den Ham, W de Jager, JW Bijlsma, BJ Prakken, RJ de Boer Differential cytokine profiles in juvenile idiopathic arthritis subtypes revealed by cluster analysis Rheumatology (Oxford) 48 2009 899 905
83. FH Prince, M Twilt, R ten Cate et al. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register Ann Rheum Dis 68 2009 635 641
84. F De Benedetti, M Massa, P Pignatti, S Albani, D Novick, A Martini Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis J Clin Invest 93 1994 2114 2119
85. S Yokota, T Miyamae, T Imagawa et al. Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis Arthritis Rheum 52 2005 818 825 (Pubitemid 40365104)
86. V Pascual, F Allantaz, P Patel, AK Palucka, D Chaussabel, J Banchereau How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets Immunol Rev 223 2008 39 59 (Pubitemid 351986188)
87. F Allantaz, D Chaussabel, D Stichweh et al. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade J Exp Med 204 2007 2131 2144 (Pubitemid 47360874)
88. P Quartier, F Allantaz, R Cimaz et al. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial) Ann Rheum Dis 70 2011 747 754
89. W de Jager, SJ Vastert, JM Beekman et al. Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis Arthritis Rheum 60 2009 2782 2793
90. AA Grom, ED Mellins Macrophage activation syndrome: advances towards understanding pathogenesis Curr Opin Rheumatol 22 2010 561 566
91. K Zhang, J Biroschak, DN Glass et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms Arthritis Rheum 58 2008 2892 2926
92. NM Wulffraat, GT Rijkers, E Elst, R Brooimans, W Kuis Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation Rheumatology (Oxford) 42 2003 375 379 (Pubitemid 36312936)
93. M Frosch, M Ahlmann, T Vogl et al. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis Arthritis Rheum 60 2009 883 891
94. D Foell, J Roth Proinflammatory S100 proteins in arthritis and autoimmune disease Arthritis Rheum 50 2004 3762 3771 (Pubitemid 39643922)
95. D Foell, M Frosch, A Schulze zur Wiesch, T Vogl, C Sorg, J Roth Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop? Ann Rheum Dis 63 2004 206 208 (Pubitemid 38122142)
96. D Foell, N Wulffraat, LR Wedderburn et al. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial JAMA 303 2010 1266 1273
97. D McGonagle, M Benjamin Towards a new clinico-immunopathological classification of juvenile inflammatory arthritis J Rheumatol 36 2009 1573 1574
98. MB Damasio, C Malattia, A Martini, P Toma Synovial and inflammatory diseases in childhood: role of new imaging modalities in the assessment of patients with juvenile idiopathic arthritis Pediatr Radiol 40 2010 985 998
99. P Babyn, AS Doria Radiologic investigation of rheumatic diseases Rheum Dis Clin North Am 33 2007 403 440 (Pubitemid 47534248)
100. MA van Rossum, M Boers, AH Zwinderman et al. Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite score Arthritis Rheum 52 2005 2865 2872 (Pubitemid 41369117)
101. MA van Rossum, AH Zwinderman, M Boers et al. Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method Arthritis Rheum 48 2003 507 515 (Pubitemid 36278020)
102. A Ravelli, M Ioseliani, X Norambuena et al. Adapted versions of the Sharp/van der Heijde score are reliable and valid for assessment of radiographic progression in juvenile idiopathic arthritis Arthritis Rheum 56 2007 3087 3095 (Pubitemid 47502756)
103. C Malattia, MB Damasio, F Magnaguagno et al. Magnetic resonance imaging, ultrasonography, and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis Arthritis Rheum 59 2008 1764 1772
104. TB Graham, T Laor, BJ Dardzinski Quantitative magnetic resonance imaging of the hands and wrists of children with juvenile rheumatoid arthritis J Rheumatol 32 2005 1811 1820 (Pubitemid 41324825)
105. C Malattia, MB Damasio, C Basso et al. Dynamic contrast-enhanced magnetic resonance imaging in the assessment of disease activity in patients with juvenile idiopathic arthritis Rheumatology (Oxford) 49 2010 178 185
106. HI Keen, PJ Mease, CO Bingham 3rd, JT Giles, G Kaeley, PG Conaghan Systematic review of MRI, ultrasound, and scintigraphy as outcome measures for structural pathology in interventional therapeutic studies of knee arthritis: focus on responsiveness J Rheumatol 38 2011 142 154
107. FR Miese, B Ostendorf, HJ Wittsack et al. Metacarpophalangeal joints in rheumatoid arthritis: delayed gadolinium-enhanced MR imaging of cartilage - a feasibility study Radiology 257 2010 441 447
108. N Ruperto, A Martini Use of unlabelled and off licence drugs in children - a European paediatric rule is needed to protect children BMJ 320 2000 1210 1211 (Pubitemid 30224281)
109. TP Klassen, L Hartling, M Hamm, JH van der Lee, J Ursum, M Offringa StaR Child Health: an initiative for RCTs in children Lancet 374 2009 1310 1312
110. TP Klassen, L Hartling, JC Craig, M Offringa Children are not just small adults: the urgent need for high-quality trial evidence in children PLoS Med 5 2008 e172
111. N Ruperto, A Martini International research networks in pediatric rheumatology: the PRINTO perspective Curr Opin Rheumatol 16 2004 566 570 (Pubitemid 39128326)
112. EH Giannini, N Ruperto, A Ravelli, DJ Lovell, DT Felson, A Martini Preliminary definition of improvement in juvenile arthritis Arthritis Rheum 40 1997 1202 1209 (Pubitemid 27430130)
113. LN Moorthy, MG Peterson, AL Hassett, TJ Lehman Burden of childhood-onset arthritis Pediatr Rheumatol Online J 8 2010 20
114. K Minden, M Niewerth, J Listing et al. The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database Clin Exp Rheumatol 27 2009 863 869
115. N Ruperto, KJ Murray, V Gerloni et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate Arthritis Rheum 50 2004 2191 2201 (Pubitemid 38924397)
116. E Silverman, R Mouy, L Spiegel et al. Leflunomide or methotrexate for juvenile rheumatoid arthritis N Engl J Med 352 2005 1655 1666 (Pubitemid 40530232)
117. E Silverman, L Spiegel, D Hawkins et al. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis Arthritis Rheum 52 2005 554 562 (Pubitemid 40216320)
118. DJ Lovell, N Ruperto, S Goodman et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis N Engl J Med 359 2008 810 820
119. N Ruperto, DJ Lovell, R Cuttica et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis Arthritis Rheum 56 2007 3096 3106 (Pubitemid 47502757)
120. DJ Lovell, EH Giannini, A Reiff et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis - pediatric rheumatology collaborative study group N Engl J Med 342 2000 763 769 (Pubitemid 30151920)
121. N Ruperto, DJ Lovell, P Quartier et al. Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis Arthritis Rheum 62 2010 1792 1802
122. N Ruperto, DJ Lovell, P Quartier et al. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial Lancet 372 2008 383 391
123. P Woo, N Wilkinson, AM Prieur et al. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement Arthritis Res Ther 7 2005 R1281 R1288
124. G Simonini, L Cantarini, C Bresci, M Lorusso, M Galeazzi, R Cimaz Current therapeutic approaches to autoimmune chronic uveitis in children Autoimmun Rev 9 2010 674 683
125. S Magni-Manzoni, N Ruperto, A Pistorio et al. Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis Arthritis Rheum 59 2008 1120 1127
126. CA Wallace, N Ruperto, E Giannini Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis J Rheumatol 31 2004 2290 2294 (Pubitemid 39453253)
127. N Ruperto, DJ Lovell, R Cuttica et al. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension Ann Rheum Dis 69 2010 718 722
128. DJ Lovell, A Reiff, NT Ilowite et al. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis Arthritis Rheum 58 2008 1496 1504 (Pubitemid 351705939)
129. G Horneff, A Ebert, S Fitter et al. Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis Rheumatology (Oxford) 48 2009 916 919
130. G Horneff, F De Bock, I Foeldvari et al. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry Ann Rheum Dis 68 2009 519 525
131. PJ Hashkes, Y Uziel, RM Laxer The safety profile of biologic therapies for juvenile idiopathic arthritis Nat Rev Rheumatol 6 2010 561 571
132. P Diak, J Siegel, L La Grenade, L Choi, S Lemery, A McMahon Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration Arthritis Rheum 62 2010 2517 2524
133. JF Simard, M Neovius, S Hagelberg, J Askling Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study Arthritis Rheum 62 2010 3776 3782
134. N Ruperto, A Martini Pediatric rheumatology: JIA, treatment and possible risk of malignancies Nat Rev Rheumatol 7 2011 6 7
135. MY Smith, RE Sobel, CA Wallace Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry Arthritis Care Res (Hoboken) 62 2010 800 804
136. N Ruperto, EH Giannini, A Pistorio, HI Brunner, A Martini, DJ Lovell Is it time to move to active comparator trials in juvenile idiopathic arthritis? A review of current study designs Arthritis Rheum 62 2010 3131 3139
137. TJ Lehman The future of pediatric rheumatology: many questions remain Arthritis Rheum 56 2007 2815 2816 (Pubitemid 47502726)